PERCF (Percheron Therapeutics) Common Stock: $74.45 Mil (As of Dec. 2025)


What is Percheron Therapeutics Common Stock?

Percheron Therapeutics PERCF -0.18% Common Stock is $74.45 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Percheron Therapeutics's quarterly common stock declined from Dec. 2024 ($78.16 Mil) to Jun. 2025 ($72.95 Mil) but then increased from Jun. 2025 ($72.95 Mil) to Dec. 2025 ($74.45 Mil).

Percheron Therapeutics's annual common stock increased from Jun. 2023 ($65.95 Mil) to Jun. 2024 ($72.62 Mil) and increased from Jun. 2024 ($72.62 Mil) to Jun. 2025 ($72.95 Mil).

Percheron Therapeutics Common Stock Historical Data

* Premium members only.

The historical data trend for Percheron Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Percheron Therapeutics Common Stock Chart

Percheron Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 58.89 68.96 65.95 72.62 72.95

Percheron Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.21 72.62 78.16 72.95 74.45

Percheron Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $74.45 Mil mean?
Percheron Therapeutics (PERCF) has a Common Stock of $74.45 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Percheron Therapeutics and its competitors.
Is Percheron Therapeutics' Common Stock too high?
Percheron Therapeutics' current Common Stock is $74.45 Mil.
How does Percheron Therapeutics' Common Stock compare to ZTS?
Percheron Therapeutics' Common Stock of $74.45 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Percheron Therapeutics and its competitors. Percheron Therapeutics's current Common Stock is $74.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Percheron Therapeutics stock overvalued right now?
Percheron Therapeutics (PERCF) has a current Common Stock of $74.45 Mil. The current Common Stock is $74.45 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Percheron Therapeutics (PERCF), the current Common Stock is $74.45 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Percheron Therapeutics Business Description

Other Exchanges AWY0:GermanyPER:Australia
Address 35 Collins Street, Level 30, Collins Place, Melbourne, VIC, AUS, 3000
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.